Back to Results

Life Stem Genetics (LIFS)

Life Stem Genetics Inc. is a development-stage healthcare company whose common stock is listed on OTC Markets under the symbol LIFS. The company focuses on building stem cell therapy clinic operations with an emphasis on global expansion. Its described activities include stem cell banking, stem cell-based treatments for degenerative conditions, anti-aging applications, and therapies related to orthopedics, neurological disorders, and lung diseases. Life Stem Genetics also references additional offerings such as nutraceuticals, medical supplements, IV nutritional cocktails, hyperbaric oxygen therapy, cancer-related treatments, weight-loss services, and anti-viral therapy. The company was founded in 2012 and is based in East Stroudsburg, Pennsylvania. It also has a strategic collaborative agreement with American CryoStem Corporation.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Market Cap
OTC-LIFS
Not available
Not available
Not available
Fair
0.0%
24.583 K
Valuation • Fair Value

Life Stem Genetics (OTC-LIFS) Fair Value by Valuation Model

No usable valuation estimate is currently available for Life Stem Genetics (OTC-LIFS); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Life Stem Genetics (OTC-LIFS). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Life Stem Genetics (OTC-LIFS)

Review the profitability and growth indicators currently supported by the latest data.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Life Stem Genetics (OTC-LIFS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Life Stem Genetics (OTC-LIFS)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Life Stem Genetics (OTC-LIFS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Life Stem Genetics (OTC-LIFS)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Life Stem Genetics (OTC-LIFS). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Life Stem Genetics (OTC-LIFS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Life Stem Genetics (OTC-LIFS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Life Stem Genetics (OTC-LIFS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Life Stem Genetics (OTC-LIFS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Life Stem Genetics (OTC-LIFS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Life Stem Genetics (OTC-LIFS) Stock FAQ

Data-supported answers about Life Stem Genetics (OTC-LIFS), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Fair
Current financial-health read

A reliable fair value estimate is not currently available for Life Stem Genetics (OTC-LIFS). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Life Stem Genetics (OTC-LIFS) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Life Stem Genetics (OTC-LIFS).

The current market capitalization listed for Life Stem Genetics is 24.583 K.

The ticker symbol for Life Stem Genetics is OTC-LIFS, and the stock is listed on OTC Markets.

Life Stem Genetics (OTC-LIFS) is listed on OTC Markets.

Similar Healthcare Providers & Services Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

UNH NYSE Unitedhealth Group Fair Value Fair Market Cap 338.3 B
CVS NYSE CVS Health Corp Fair Value Undervalued Market Cap 113.6 B
MCK NYSE McKesson Corporation Fair Value Undervalued Market Cap 102 B
HCA NYSE HCA Holdings Inc Fair Value Fair Market Cap 92.6 B
ELV NYSE Elevance Health Inc Fair Value Fair Market Cap 89.122 B
CI NYSE Cigna Corp Fair Value Bargain Market Cap 72.74 B
COR NYSE Cencora Inc Fair Value Undervalued Market Cap 58.924 B
CAH NYSE Cardinal Health Inc Fair Value Fair Market Cap 52.418 B
HUM NYSE Humana Inc Fair Value Fair Market Cap 46.377 B
CNC NYSE Centene Corp Fair Value Fair Market Cap 32.164 B
DGX NYSE Quest Diagnostics Incorporated Fair Value Fair Market Cap 27.202 B
LH NYSE Labcorp Holdings Inc Fair Value Fair Market Cap 26.01 B
GH NASDAQ Guardant Health Inc Fair Value Overvalued Market Cap 24.072 B
THC NYSE Tenet Healthcare Corporation Fair Value Fair Market Cap 21.095 B
EHC NYSE Encompass Health Corp Fair Value Fair Market Cap 12.011 B
BTSG NASDAQ Brightspring Health Services Inc Fair Value Fair Market Cap 11.838 B
FMS NYSE Fresenius Medical Care Corporation Fair Value Undervalued Market Cap 11.778 B
DVA NYSE DaVita HealthCare Partners Inc Fair Value Fair Market Cap 11.725 B
MOH NYSE Molina Healthcare Inc Fair Value Undervalued Market Cap 10.459 B
UHS NYSE Universal Health Services Inc Fair Value Undervalued Market Cap 10.413 B